Expression of glutamate transporter subtypes in cultured retinal pigment epithelial and retinoblastoma cells

Current Eye Research

Volumn 28, Issue 3, 2004, Pages 159-165

  Mäenpää, Hanna ^a,b   Gegelashvili, Georgi ^c   Tähti, Hanna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

EAAC1; EAAT4; Glutamate; Glutamate transporter; Retinal pigment epithelium

Indexed keywords

CHLORIDE CHANNEL; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; INSULIN; RETINOIC ACID; TAMOXIFEN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIUM CELL; EVALUATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INHIBITION KINETICS; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETINOBLASTOMA; SWINE; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEM X-AG; AMINO ACID TRANSPORT SYSTEMS; ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL DIVISION; CELL LINE, TRANSFORMED; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; EXCITATORY AMINO ACID TRANSPORTER 5; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INSULIN; PHOTORECEPTORS; PIGMENT EPITHELIUM OF EYE; PROTEIN ISOFORMS; RETINAL NEOPLASMS; RETINOBLASTOMA; SWINE; SYMPORTERS; TAMOXIFEN; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 12144290828     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.28.3.159.26244     Document Type: Article

References (46)

1. Rauen T. Diversity of glutamate transporter expression and function in the mammalian retina. Amino Acids. 2000;19:53-62.
2. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23: 1261-1276.
3. Gegelashvili G, Robinson MB, Trotti D, Rauen T. Regulation of glutamate transporters in health and disease. Prog Brain Res. 2001;132:267-286.
4. Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1-105.
5. Gegelashvili G, Schousboe A. Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res Bull. 1998;45:233-238.
6. Rauen T. Diversity of glutamate transporter expression and function in the mammalian retina. Amino Acids. 2000;19: 53-62.
7. Marmor MF. Structure, function and disease of the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ, eds. The Retinal Pigment Epithelium. 1st edn. New York: Oxford University Press; 1998:3-9.
8. +-dependent glutamate transporter in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1994;35:3589-3598.
9. Mäenpää H, Mannerström M, Toimela T, Salminen L, Saransaari P, Tähti H. Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells. Pharmacol Toxicol. 2002;91:116-122.
10. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
11. Naskar R, Vorwerk CK, Dreyer EB. Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1940-1944.
12. Li Q, Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. Invest Ophthalmol Vis Sci. 2002;43:3109-3116.
13. Marc RE, Murry RF, Fisher SK, Linberg KA, Lewis GP. Amino acid signatures in the detached cat retina. Invest Ophthalmol Vis Sci. 1998;39:1694-1702.
14. Pastor JC, del, Martin F. Proliferative vitreoretinopathy: Risk factors and pathobiology. Prog Retin Eye Res. 2002;21:127-144.
15. Stroeva OG, Mitashov VI. Retinal pigment epithelium: Proliferation and differentiation during development and regeneration. Int Rev Cytol. 1983;83:221-293.
16. Grierson I, Hiscott P, Hogg P, Robey H, Mazure A, Larkin G. Development, repair and regeneration of the retinal pigment epithelium. Eye. 1994;8(Pt 2):255-262.
17. Pavlidis NA, Petris C, Briassoulis E, Klouvas G, Psilas C, Rempapis J, Petroutsos G. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer. 1992;69:2961-2964.
18. Alwitry A, Gardner I. Tamoxifen maculopathy. Arch Ophthalmol. 2002;120:1402-1402.
19. Davis AA, Bernstein PS, Bok D, Turner J, Nachtigal M, Hunt RC. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol Vis Sci. 1995;36:955-964.
20. Gegelashvili G, Dehnes Y, Danbolt NC, Schousboe A. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int. 2000;37:163-170.
21. Mannerström M, Zorn-Kruppa M, Diehl H, Engelke M, Toimela T, Mäenpää H, Huhtala A, Uusitalo H, Salminen L, Pappas P, Marselos M, Mäntylä M, Mäntylä E, Tähti H. Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells. Toxicol in Vitro. 2002;16:193-200.
22. Bridges CC, Kekuda R, Wang H, Prasad PD, Mehta P, Huang W, Smith SB. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2001;42:47-54.
23. Derouiche A, Rauen T. Coincidence of L-glutamate/L-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: Evidence for coupling of GLAST and GS in transmitter clearance. J Neurosci Res. 1995;42:131-143.
24. Lehre KP, Davanger S, Danbolt NC. Localization of the glutamate transporter protein GLAST in rat retina. Brain Res. 1997;744:129-137.
25. Otori Y, Shimada S, Tanaka K, Ishimoto I, Tano Y, Tohyama M. Marked increase in glutamate-aspartate transporter (GLAST/GluT-1) mRNA following transient retinal ischemia. Brain Res Mol Brain Res. 1994;27:310-314.
26. Kyritsis AP, Tsokos M, Triche TJ, Chader GJ. Retinoblastoma: A primitive tumor with multipotential characteristics. Invest Ophthalmol Vis Sci. 1986;27:1760-1764.
27. Ganel R, Crosson CE. Modulation of human glutamate transporter activity by phorbol ester. J Neurochem. 1998; 70:993-1000.
28. Gegelashvili G, Danbolt NC, Schousboe A. Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia. J Neurochem. 1997;69:2612-2615.
29. Plachez C, Danbolt NC, Recasens M. Transient expression of the glial glutamate transporters GLAST and GLT in hippocampal neurons in primary culture. J Neurosci Res. 2000;59:587-593.
30. Pow DV. Amino acids and their transporters in the retina. Neurochem Int. 2001;38:463-484.
31. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
32. Hiscott P, Sheridan CM. The retinal pigment epithelium, epiretinal membrane formation, and proliferative vitreoretinopathy. In: Marmor MF, Wolfensberger TJ, eds. The Retinal Pigment Epithelium. 1st edn. New York: Oxford University Press; 1998:478-491.
33. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature. 1995;375:599-603.
34. Gegelashvili G, Danbolt NC, Dehnes Y, Balazs R, Cribbs DH, Cotman CW, Rodriguez-Kern A, Gegelashvili M. Caspase-dependent regulation and receptor-like properties of glutamate transporters. Society for Neuroscience Abstracts. 2002;441:16.
35. Jackson M, Song W, Liu MY, Jin L, Dykes H, Lin CI, Bowers WJ, Federoff HJ, Sternweis PC, Rothstein JD. Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature. 2001;410:89-93.
36. + ion channel blockers. J Neurosci. 1999;19:5942-5954.
37. Mäenpää H, Saransaari P, Tähti H. Kinetics of inhibition of glutamate uptake by antioestrogens. Pharmacol Toxicol. 2003;92:in press.
38. Cyr M, Thibault C, Morissette M, Landry M, Di P. Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain. Neuropsychopharmacology. 2001;25:242-257.
39. Freund WD, Grieshop B, Neumann U, Reddig S. Glutamate-induced calcium responses in rat primary cortical cultures are potentiated by co-administration of glutamate transport inhibitors. Neurosci Lett. 1995;188:61-64.
40. Engelke M, Tykhonova S, Zorn K, Diehl H. Tamoxifen induces changes in the lipid composition of the retinal pigment epithelium cell line d407. Pharmacol Toxicol. 2002;91:13-21.
41. Phillis JW, Song D, Regan MH. Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex. Brain Res. 1998;780: 352-355.
42. Zhang JJ, Jacob TJ, Valverde MA, Hardy SP, Mintenig GM, Sepulveda FV, Gill DR, Hyde SC, Trezise AE, Higgins CF. Tamoxifen blocks chloride channels. A possible mechanism for cataract formation. J Clin Invest. 1994;94:1690-1697.
43. Butchbach ME, Guo H, Lin CL. Methyl-beta-cyclodextrin but not retinoic acid reduces EAAT3-mediated glutamate uptake and increases GTRAP3-18 expression. J Neurochem. 2003;84:891-894.
44. Janssen JJ, Kuhlmann ED, van Vugt AH, Winkens HJ, Janssen BP, Deutman AF, Driessen CA. Retinoic acid delays transcription of human retinal pigment neuroepithelium marker genes in ARPE-19 cells. Neuroreport. 2000; 11:1571-1579.
45. Campochiaro PA, Hackett SF, Conway BP. Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1991;32:65-72.
46. Chen S, Samuel W, Fariss RN, Duncan T, Kutty RK, Wiggert B. Differentiation of human retinal pigment epithelial cells into neuronal phenotype by N-(4-hydroxyphenyl)retinamide. J Neurochem. 2003;84:972-981.